![TEVA - Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Stock - Stock Price, Institutional Ownership, Shareholders (NYSE) TEVA - Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)](https://images.fintel.io/us-teva-put-call-ratio.png)
TEVA - Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)
![Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily](https://www.investors.com/wp-content/uploads/2018/01/stock-Teva-03-company.jpg)
Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily
![Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business](https://media.cnn.com/api/v1/images/stellar/prod/230821162715-teva-pharmaceuticals-file-restricted.jpg?c=original)
Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business
TEVA Stock Sees Positive Momentum as Bank of America Analyst Maintains Strong Buy Rating | WallStreetZen
![Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday | Markets Insider Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday | Markets Insider](https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/02/12/teva_pharmaceutical_-_logo.jpg)
Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday | Markets Insider
![Teva Pharmaceutical Industries Ltd and Sanofi Join to Develop Bowel Disease Treatment | Stock Target Advisor Teva Pharmaceutical Industries Ltd and Sanofi Join to Develop Bowel Disease Treatment | Stock Target Advisor](https://www.stocktargetadvisor.com/blog/wp-content/uploads/2022/01/teva-banner.jpg)